Related Experiment Videos
Nonpeptide mediators in the hematopoietic microenvironment.
Robert Mohle1, Andreas M Boehmler, Claudio Denzlinger
1Department of Medicine II, University of Tübingen, Tübingen, Germany. robert.moehle@med.uni-tuebingen.de
Annals of the New York Academy of Sciences
|June 12, 2003
Summary
Hematopoietic stem cell migration involves multiple G protein-coupled receptors (GPRs), not just CXCR4. These receptors interact, suggesting new therapeutic targets for modulating stem cell mobilization and homing.
Area of Science:
- Hematology
- Cell Biology
- Immunology
Background:
- Hematopoietic stem and progenitor cell (HPC) migration is crucial for blood formation and is regulated by the hematopoietic microenvironment.
- The chemokine SDF-1 (stromal cell-derived factor-1) and its receptor CXCR4 are known key regulators of HPC mobilization and homing.
Purpose of the Study:
- To investigate the role of other G protein-coupled receptors (GPRs) beyond CXCR4 in regulating HPC migration and adhesion.
- To explore potential cross-talk between different GPRs in response to their ligands.
Main Methods:
- Utilized CD34(+) hematopoietic progenitors.
- Investigated the effects of non-peptide GPR ligands, such as cysteinyl-leukotriene receptor CysLT1 agonists.
- Assessed HPC migration and integrin-dependent adhesion.
- Examined the impact of continuous GPR activation on the responsiveness of other GPRs.
Main Results:
- Ligands for GPRs other than CXCR4, including CysLT1, stimulate HPC migration and integrin-dependent adhesion.
- Continuous activation of one GPR upregulates the responsiveness of other GPRs to their ligands.
- HPC migration and homing appear to involve a network of interacting GPRs and adhesion molecules, rather than a single receptor system.
Conclusions:
- HPC migration and homing are regulated by a complex interplay of multiple GPRs, not solely by the CXCR4/SDF-1 axis.
- These findings reveal novel mechanisms controlling stem cell trafficking.
- Pharmacological modulation of GPRs offers potential therapeutic strategies for controlling HPC mobilization and homing.